Summary We previously reported that combined treatment with melphalan and mild hyperthermia (1 h at 42°C) caused a synergistic cytotoxic effect in JR8 melanoma cells, paralleled by a stabilisation of a melphalaninduced G2-phase cell block. In this study, we investigated the effect of melphalan and hyperthermia on proteins that regulate G2 -M transition. Neither hyperthermia nor melphalan at a concentration of 2.5 ,ug ml -, which had no antiproliferative effect at 37°C, interfered with cyclin B1 expression or p34cdc2 kinase activity. At a concentration of 8.5 Mg ml -, which reduced cell growth by 50% at 37°C, melphalan inhibited p34cdc2 kinase activity as a consequence of an increased tyrosine phosphorylation of the protein. A similar inhibitory effect on p34c2 kinase was obtained when the lowest melphalan concentration (2.5 ig ml-) was used under hyperthermic conditions. Our results indicate that thermal enhancement of melphalan cytotoxicity could be mediated at least in part by an inhibition of p34XCd2 kinase activity, which prevents cell progression into mitosis.
Clinical studies on melanoma (Santinami et al., 1989) have shown that hyperthermia increases the anti-tumour activity of some bifunctional alkylating agents such as L-phenylalanine mustard (melphalan, L-PAM). The mechanisms responsible for the thermal enhancement of L-PAM activity are not yet completely understood. In experimental systems (1) an increase in L-PAM influx leads to a higher intracellular drug accumulation (Bates and MacKillop, 1989) , (2) alteration of the DNA quaternary structure, which favours alkylation (Mills and Meyn, 1981) , (3) interference with drug-DNA adduct metabolism (Zaffaroni et al., 1992) and (4) inhibition of DNA repair (Jorritsma et al., 1985) have been demonstrated. Moreover, we recently showed that hyperthermia can stabilise the transient accumulation of cells in G2-phase induced by L-PAM in human melanoma cells (Orlandi et al., 1995) .
Considerable progress has been made in understanding the proteins which regulate cell cycle progression. Specifically, the primary participants in G2 M transition are a cyclindependent kinase, p34 Ic2 and the cyclin B protein, which regulates the activity of the kinase (Lewin, 1990; Nurse, 1990; Solomon et al., 1990) . Here, we investigated the effect exerted by L-PAM, under normothermic and hyperthermic conditions, on the expression of cyclin B1 protein as well as on the catalytic activity of p34cdc2 kinase in a human melanoma cell line.
Materials and methods

Cell line
The human melanoma cell line JR8 (Zupi et al., 1985) was grown at 37°C in a 5% carbon dioxide humidified atmosphere in air, with RPMI-1640 medium (Bio Whittaker, Verviers, Belgium), containing 10% fetal calf serum (Biological Industries, Kibbutz Beth Haemek, Israel), 2 mM L-glutamine and gentamycin (0.1 mg ml-'). During the phase of exponential growth, JR8 cells have a doubling time of about 24 h. All experiments were performed within the tenth passage after thawing.
Heat and drug treatments Cells were exposed to heat by placing T-25 flasks in a controlled precision water bath at 42°C (+0.05°C) for 1 h. For treatment with L-PAM (Sigma, St Louis, MO, USA) in normothermic or hyperthermic conditions, cells were exposed for 1 h to different drug concentrations or to the drug solvent (control samples). The temperature and exposure times were chosen because they correspond to the treatment perfusion in melanoma patients (Vaglini et al., 1986; Ghussen et al., 1988) . Following treatment with hyperthermia, L-PAM, or both, cells were rinsed with phosphate-buffered saline (PBS) and fed with fresh medium. Each experimental point was run in triplicate. Experiments were repeated three times. Treatmentinduced cytotoxicity was determined with a 96 h growth inhibition assay by using an electronic cell counter (Coulter Electronics, Hialeah, FL, USA) as previously described (Orlandi et al., 1995 the primary monoclonal antibody anti-p34cdc2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Unbound antibody was removed and filters were then incubated with the secondary antibody anti-mouse Ig horseradish peroxidaselinked whole antibody (Amersham, Bucks, UK). Bound antibody was detected using the enhanced chemiluminescence Western blotting detection system (Amersham). To reprobe with alternative antisera, the membranes were immersed in a stripping solution (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris, pH 6.7) for 30 min at 50°C.
Non-specific binding sites were blocked in 5% skim milk/ TBS-T and the filter reprobed with anti-phosphotyrosine (Boehringer Mannheim, Mannheim, Germany) as primary antibody.
Immunoprecipitation and histone H, kinase assay Total cellular protein (100 pjg), obtained by lysing cells with RIPA buffer as described before, was immunoprecipitated by anti-p34cdc2 agarose conjugate (Santa Cruz Biotechnology) for 4 h at 4°C. Immunoprecipitates were then washed four times with RIPA buffer and resuspended in 50 pl of kinase buffer containing 50 mM Tris, pH 7.4, 10 mM magnesium chloride, 1 mM dithiothreitol and 50 jg ml-' histone H, (Boehringer Mannheim) . Following a preincubation of 10 min at 30°C, reactions were started by the addition of 10 ,iCi of [y-32P]ATP (specific activity 3000 Ci mmol-1), incubated at 30°C for 20 min, and stopped by the addition of 50 kl of 2 x SDS gel loading buffer. The mixtures were denatured at 95°C for 5 min and separated on 12% SDS-polyacrylamide gel. Bands were detected by autoradiography and quantified by an Ultrascan XL enhanced laser densitometer (LKB, Turku, Finland). (-6%) in cell proliferation at the lowest concentration of 2.5 jug ml-'. The growth inhibitory effect was considerably higher (-50%) when cells were exposed to the highest drug concentration of 8.5 jug ml-'. A similar antiproliferative effect (-46%) was reached after combined treatment with 2.5 ,ug ml-1 L-PAM under hyperthermic conditions. Effect of hyperthermia and/or L-PAM on the catalytic activity of p34cdc2 kinase At 48 h and 72 h after treatment, the JR8 cell extract was immunoprecipitated by using anti-p34 lc2 antibody and the kinase activity measured by using histone H, as a substrate (Figure 2 ). Immunoprecipitates obtained from cells treated with hyperthermia or with 2.5 pg ml-' L-PAM phosphorylated histone H, to a similar degree as in control cells (Table   48 (Figure 3 , upper panel and Table II ). Since p34cdc2 catalytic activity is known to be modulated by phosphorylation of its tyrosine and threonine residues, we also investigated the effect of hyperthermia and L-PAM, singly or in association, on the phosphorylation state of p34c"C2. The immunoblots with anti-phosphotyrosine antibody ( Figure 3 , lower panel and Table II) showed that samples treated with hyperthermia alone or with 2.5 pg ml-' L-PAM exhibited a p34cdc2 tyrosine phosphorylation similar to that of control samples. Conversely, samples exposed to 8.5 pg ml-' L-PAM showed an increase in the degree of tyrosine phosphorylation. A similarly pronounced increase was observed in samples exposed to the combined treatment with 2.5 pg ml-' L-PAM and hyperthermia.
Discussion
We investigated the effect of hyperthermia and L-PAM on G2 -M transition in a human melanoma cell line. A 1 h exposure to 42°C did not affect the growth of JR8 cells. Such a result is in agreement with previous evidence by our (Zaffaroni et al., 1992; Orlandi et al., 1993 Orlandi et al., , 1995 and other groups (Rofstad et al., 1990) , indicating a negligible effect of mild hyperthermia itself on human melanoma-established cell lines and primary cultures. Moreover, clinically mild hyperthermia is devoid of any significant anti-tumour effect, and it is generally used in conjunction with alkylating agents to modulate drug activity positively in drug-refractory tumours, such as melanoma (Santinami et al., 1989; Ghussen et al., 1988) . In JR8 cells, hyperthermia markedly increased the cytotoxic effect of a low L-PAM concentration and stabilised the transient L-PAM-induced G2 accumulation. Under normothermic conditions, such a low L-PAM concentration only induced a negligible inhibitory effect on cell growth and a modest increase in G2 cell fraction, (Konopa, 1988) . In a previous study on melanoma primary cultures, we demonstrated that hyperthermia was able to increase the accumulation of L-PAM-induced DNA interstrand cross-links and to prevent their long-term removal (Zaffaroni et al., 1992) . However, the coupling of DNA damage to cell cycle perturbation induced by L-PAM is still largely unclear.
Hyperthermia could also stabilise L-PAM-induced G2 accumulation through an inhibitory effect on proteins that regulate G2-M transition. Such a transition in eukaryotic cells is controlled by a mitosis-promoting factor (MPF), which consists of a regulatory subunit, a specific B-type cyclin, and the catalytic subunit, p34cdc2 kinase (Lewin, 1990; Nurse, 1990; Norbury and Nurse, 1992 Exposure to the highest L-PAM concentration at 37°C, as well as to the lowest one at 42°C, enhanced the level of tyrosine phosphorylation of p34cdc2. Such an effect was more pronounced after combined L-PAM/hyperthermia treatment. Since activation of MPF results from the dephosphorylation of cyclin B-bound p34Cdc2, our findings suggest that a treatment-induced G2 accumulation results from the inability to activate MPF. The lack of MPF activity may be due to an up-regulation of cdc2 tyrosine kinase activity or a downregulation of tyrosine phosphatase activity. Recent data (O'Connor et al., 1992) indicated that inhibition of p34cdc2 kinase activity by another bifunctional alkylating agent, nitrogen mustard (HN2), on lymphoma cells was consequent on a down-regulation of the cdc25 tyrosine phosphatase (O'Connor et al., 1994) .
On the whole, our results indicate thermal stabilisation of cell cycle perturbations induced by L-PAM as one of the possible mechanisms for the enhancement of L-PAM cytotoxic activity under hyperthermic conditions. Specifically, hyperthermia seems to enhance the inhibition of p34cdc2 kinase activity induced by L-PAM as a consequence of an increased tyrosine phosphorylation of the protein.
